So we headed to NYC early Thursday morning in search of the “Teenage Mutant Ninja Turtles.” After touching down at LaGuardia we climbed into a yellow taxi held together by duct tape, rode over potholed streets with our cell phone cutting in and out (gosh I love New York City), and arrived at Grand Central Terminal around 11:00 a.m. Our room at the Hyatt was not ready so we hit the streets looking for the turtles. What we found at 39th and Lexington was not Donatello, but Maximo, proprietor of Sam’s Place, an Italian eatery of very high report, and Max is my new best friend. We sat down, with nobody else yet in the restaurant (soon it was packed), and Max and I discussed the other restaurateurs that we know only to have our friends, Federated Investors’ Phil Orlando and Stephen Chiavarone, show up for our lunch. Obviously, we discussed the various markets, as well as individual stocks. We told them that while riding in from LaGuardia we fielded a phone call from CNBC’s Patti Domm as the D-J Industrials were printing down some 350 points. We told Patti the weakness came from comments made by one of Washington D.C.’s best and brightest who had whispered that the Chinese trade talks were not going well. We also mention a quote from our dearly departed friend Richard Russell (Dow Theory Letters), “When the President is in trouble, the stock market is in trouble!” We concluded to Patti that it was just noise and investors should buy the Dow Diamonds (DIA/$242.52), which at the time were changing hands around $238. Shortly thereafter Mark Calabria, a White House economist, came out and refuted the negative trade talk comments, and the rest as they say is history, as the D-J Industrials closed up for the whipsaw session.
Our lunch was over around 1:45 p.m. and I journeyed back to the Grand Central Hyatt to check in and meet a friend. From there he and I rode the number 4 express subway down to Wall Street where we walked the NYSE floor and I introduced him to a number of other friends before appearing on CNBC’s “Closing Bell” with basically the same message I told to Patti Domm earlier, “buy ‘em!” Appearance done, we strolled across the street to Bobby Van’s for the typical 4:15 p.m. meeting of Friends of Fermentation, which is where the iconic Arthur Cashin holds court. That was followed by dinner with Eric Kaufman and Victoria, who in my opinion are among the best MLP-centric portfolio managers in the business.
The next morning it was breakfast with my long-time friend Mary Lisanti, eponymous portfolio manager of Lisanti Capital Growth, a New York-based, women-owned investment management firm specializing in small and SMID cap growth investing. I have known Mary Lisanti for years, and have owned her fund for years (ASCGX/$19.97) because over the long cycle I believe Mary is going to make me money. We discussed many stocks, but the only one that is followed by Raymond James’ fundamental analysts, with a positive rating, is Insulet (PODD/$83.88/Outperform). As our fundamental analyst writes:
On Friday (3/9/18) after the close, Insulet announced a partnership with United Healthcare (UNH). The agreement will allow UNH to begin covering the Omnipod effective April 1, 2018. Previously, only ~5% of Insulet’s customer base stemmed from United policyholders as these customers had to go through a third-party distributor to obtain the Omnipod. This coverage decision will allow for direct access for United policyholders. According to management, pricing will be “in-line” with the rest of the commercial business.
This is a pretty big deal because it gives Insulet access to United Healthcare’s 70M covered lives.